Abstract: The present invention relates to a pharmaceutical composition for topical administration comprising a compound of formula I, 3-{4-[2-{5-chloro-1-(diphenylmethyl)-2-[2-({[2-(trifluoromethyl)benzyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethyl]sulfonyl}phenyl}propanoic acid: or pharmaceutically acceptable salts thereof; and to methods of treating inflammation comprising topical administration of a compositions comprising a compound of formula I.
Type:
Grant
Filed:
February 4, 2015
Date of Patent:
July 4, 2017
Assignee:
Ziarco Pharma Limited
Inventors:
Wai Leung Liu, Lynn Purkins, Michael Yeadon